Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KSY Extract for Hepatitis C
NCT01708733Phase 3Completed
- Sponsor
- Taipei City Hospital
- Start
- Aug 2012
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Kuan-Sin-Yin in hepatitis C (HCV) (2 arms), sponsored by Taipei City Hospital. Primary endpoint: HCV RNA titer at 6 weeks. Started Aug 2012; status: completed.
02
Drugs
Kuan-Sin-Yin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01708733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01708733.